Entropy Technologies’s Dynavax Technologies DVAX Stock Holding History

Entropy Technologies’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-39,644	Closed	-$610K	–	951
2025 Q4	$610K	Sell	39,644 -8,937	-18%	-$98.4K	0.03%	509
2025 Q3	$482K	Buy	48,581 +29,396	+153%	+$306K	0.04%	531
2025 Q2	$190K	Sell	19,185 -83,649	-81%	-$881K	0.02%	713
2025 Q1	$1.33M	Buy	102,834 +54,213	+112%	+$717K	0.13%	217
2024 Q4	$621K	Buy	48,621 +7,121	+17%	+$86.1K	0.06%	391
2024 Q3	$462K	Buy	+41,500	New	+$457K	0.05%	454

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Entropy Technologies's DVAX Position: Q1 2026 in Review

Entropy Technologies sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 39,644 shares — an estimated $610K sold.

Entropy Technologies first reported a position in DVAX in Q3 2024 and held it in 6 quarters. The position peaked at $1.33M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Entropy Technologies reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Entropy Technologies sold 39,644 Dynavax Technologies shares in Q1 2026, an estimated $610K.
Entropy Technologies first reported a position in Dynavax Technologies in Q3 2024 and held it in 6 quarters.
Entropy Technologies's Dynavax Technologies position peaked at $1.33M in Q1 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.